Loading
EG
Edding Genor Group Holdings Ltd. Stock: price and insider trades · Hong Kong
1 insider bought €785k of shares over the last 90 days, the latest by Ni Xin, filed 16 Sept 2026.
Edding Genor Group Holdings Ltd.: what insiders have been doing
Every trade that managers of Edding Genor Group Holdings Ltd. disclose to HKEX is tracked on this page. The company sits in the Health Care sector. In the past year (19 October 2025 to 19 October 2026), 27 filings came from 3 insiders.
Only purchases show up on the open market, 23 purchases in all worth €1.7M, filed by 1 insider. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €451k from Ni Xin, disclosed on 16 September 2026, or 0.12% of market capitalisation. Those buying include 1 senior executive.
The latest purchase dates back some time: it was published 38 days ago, on 16 September 2026. Filings reach the HKEX feed a median of 5 days after the trade. Until a filing is published, the market cannot know about the trade.
Compared with its exchange (1,147 companies, median 5 filings), a count of 27 filings is above the norm. Since 2020, the database holds 25 purchases and 2 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Vivos Inc and Anixa Biosciences Inc. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Insider Decl.
42
Thresholds
n/a
Buy Volume
€2M
25 ops. · all time
Sell Volume
€225,151
2 ops. · all time
Who traded when
BuySaleNi Xin23 buys
Since the insiders bought
- -0.3%Entry HK$1.65 · Close 16 Oct 2026 HK$1.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,536 of 26,280 companies
78.1
score / 100
Value88
Quality68
FCF yld12%
Earn yld12%
EV/EBITDA5.2x
ROE6.7%
Gross mgn68%
Net mgn16%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$1.64
Analyst consensus
Income statement
RevenueHK$2.5B
Gross profitHK$1.7B68% margin
EBITDAHK$905.3M36% margin
Net incomeHK$399.3M9.8% margin
Valuation
PER (trailing)10.3x
P/Book0.7x
Beta0.99
Balance sheet & cash
Market capHK$3.2B
Total debtHK$1.5B
Free Cash FlowHK$404M
Debt / Equity30%
Profitability & ownership
ROE6.7%
ROA4.7%
% insiders47.4%
% institutions25.9%
Last declaration on 16 September 2026
Declarations42 total
13,000 shares@ HK$1.76080.0007% mcap0.2% of flowShareXHKGHKEX:DA20260916E00091
Canonical exit: 14 Dec 2026 (T+90)
2,410,000 shares@ HK$1.70150.12% mcap27.2% of flowShareXHKGHKEX:DA20260916E00090
Canonical exit: 13 Dec 2026 (T+90)
200,000 shares@ HK$1.700.010% mcap2.2% of flowShareXHKGHKEX:DA20260916E00072
Canonical exit: 10 Dec 2026 (T+90)
200,000 shares@ HK$1.74450.010% mcap2.3% of flowShareXHKGHKEX:DA20260914E00004
Canonical exit: 9 Dec 2026 (T+90)
200,000 shares@ HK$1.68860.0100% mcap2.2% of flowShareXHKGHKEX:DA20260914E00003
Canonical exit: 8 Dec 2026 (T+90)
116,500 shares@ HK$1.68590.0058% mcap1.3% of flowShareXHKGHKEX:DA20260910E00266
Canonical exit: 7 Dec 2026 (T+90)
150,000 shares@ HK$1.68920.0075% mcap1.7% of flowShareXHKGHKEX:DA20260910E00265
Canonical exit: 6 Dec 2026 (T+90)
311,000 shares@ HK$1.66060.015% mcap3.4% of flowShareXHKGHKEX:DA20260909E00029
Canonical exit: 3 Dec 2026 (T+90)
150,000 shares@ HK$1.64690.0073% mcap1.6% of flowShareXHKGHKEX:DA20260907E00218
Canonical exit: 2 Dec 2026 (T+90)
150,000 shares@ HK$1.61660.0072% mcap1.6% of flowShareXHKGHKEX:DA20260907E00217
Canonical exit: 1 Dec 2026 (T+90)
150,000 shares@ HK$1.64890.0073% mcap1.6% of flowShareXHKGHKEX:DA20260903E00358
Canonical exit: 30 Nov 2026 (T+90)
185,000 shares@ HK$1.57640.0087% mcap1.9% of flowShareXHKGHKEX:DA20260903E00357
Canonical exit: 29 Nov 2026 (T+90)
100,000 shares@ HK$1.77730.0046% mcap1.2% of flowShareXHKGHKEX:DA20260626E00387
Canonical exit: 23 Sept 2026 (T+90)
100,000 shares@ HK$1.79470.0047% mcap1.2% of flowShareXHKGHKEX:DA20260626E00386
Canonical exit: 22 Sept 2026 (T+90)
200,000 shares@ HK$1.79860.0093% mcap2.4% of flowShareXHKGHKEX:DA20260625E00326
Canonical exit: 21 Sept 2026 (T+90)
200,000 shares@ HK$1.81920.0094% mcap2.4% of flowShareXHKGHKEX:DA20260625E00325
Canonical exit: 20 Sept 2026 (T+90)
823,000 shares@ HK$1.87850.050% mcap10.4% of flowShareXHKGHKEX:DA20260624E00033
Canonical exit: 16 Sept 2026 (T+90)
334,500 shares@ HK$1.76430.019% mcap3.9% of flowShareXHKGHKEX:DA20260622E00004
Canonical exit: 14 Sept 2026 (T+90)
200,000 shares@ HK$1.8050.012% mcap2.4% of flowShareXHKGHKEX:DA20260622E00005
Canonical exit: 15 Sept 2026 (T+90)
500,500 shares@ HK$1.79020.029% mcap5.9% of flowShareXHKGHKEX:DA20260618E00031
Canonical exit: 13 Sept 2026 (T+90)
500,000 shares@ HK$1.74630.028% mcap5.8% of flowShareXHKGHKEX:DA20260617E00082
Canonical exit: 10 Sept 2026 (T+90)
500,000 shares@ HK$1.750.028% mcap5.8% of flowShareXHKGHKEX:DA20260615E00065
Canonical exit: 9 Sept 2026 (T+90)
1,000,000 shares@ HK$1.6660.054% mcap11.1% of flowShareXHKGHKEX:DA20260615E00063
Canonical exit: 8 Sept 2026 (T+90)
9,135,258 sharesShareXHKGHKEX:DA20260401E00529
3,302,384 sharesShareXHKGHKEX:DA20260401E00521
25 of 42 declarations
About Edding Genor Group Holdings Ltd.
Edding Genor Group Holdings Ltd. is a company operating in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange, XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
